Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
- Authors: Nicolatou-Galitis, Ourania; Kouri, Maria; Papadopoulou, Erofili; Vardas, Emmanouil; Galiti, Dimitra; Epstein, Joel B; Elad, Sharon; Campisi, Giuseppina; Tsoukalas, Nikolaos; Bektas-Kayhan, Kivanc; Tan, Winston; Body, Jean-Jacques; Migliorati, Cesar; Lalla, Rajesh V
- Publication year: 2018
- Type: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/306069
Abstract
The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such as antiangiogenics, tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, immune checkpoint inhibitors, and cytotoxic chemotherapy is increasing.